Received Nov 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | Y018677 | — |
zero patients who received the affected administered doses reported any adverse issues or side effects; Caller provided the following temperature excursion information and patient information that received PEDVAX HIB after temperature excursion; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. Multiple temperature excursions occurred previously to vaccine administration (12-Sep-2025, 8.9 C for 14 minutes; 24-Sep-2025, 8.4 C for 8 minutes; 25-Sep-2025, 8.2 C for 12 minutes). On 14-Oct-2025, the patient was vaccinated with an improperly storage dose of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAX HIB), (lot #Y018677, expiration date: 10-Apr-2027) (strength, dose, frequency, and anatomical location not provided) for prophylaxis (Product storage error). Reporter stated that zero patients who received the affected administered doses reported any adverse issues or side effects. This is one of multiple reports from the same reporter.